Archive for July, 2009

h1

Electric scooters for green hipsters

July 31, 2009

By Karin Kloosterman   July 22, 2009

Bicycles are great for the environment, but you can’t arrive at work or school dripping with sweat. A new earth-friendly solution hitting the streets in New York and Tel Aviv this summer comes in the form of electric powered scooters.

Leave the car behind. The Trekker scooters, developed by Israeli Arik Yehuda.

Leave the car behind. The Trekker scooters, developed by Israeli Arik Yehuda.

With little noise, no fumes and low power needs, green hipsters everywhere are looking for Trekker, an Israeli-made and relatively inexpensive solution to get around town.

You can’t yet buy a Trekker in New York – the ones on the streets were bought in Israel and taken back by plane or shipped over – but Trekker factories are about to open in pilot sites in Europe, as a step to bringing its production one “putt” closer to the United States market.

Inventor Arik Yehuda, 41, is taking it step by step because parts and service centers need to be close by in order to provide customer service.

The electric-powered Trekkers were first conceived about five years ago in south Tel Aviv. After investigating what’s on the market, Yehuda, an engineer, developed his line of scooters, which he claims are the fastest and best. Sales began about three years ago. Today they are selling like hotcakes.

Designed according to a buyer’s specifications in hot pink, turquoise, or anything in between, “we have the knowledge to make it gas or hybrid if we want. I can make something for elderly people or for extreme people,” Yehuda tells ISRAEL21c.

Long, tall, short or small

“We can customize them for short people, or long people. We can customize from the bottom to the top,” he says. “You can pick the color and we will paint it. You can choose your rims, brakes, and suspension. Like a car. You choose whatever you want.”

As a result, the Trekker, either an electric stand-up scooter or a model that comes with a seat, can match your personal style and taste.

Yehuda’s two electric models, the 560 and the 560s with a seat, weigh in at about 66 pounds and can drive up to 18 miles an hour, even if Israeli law says they should drive no faster than seven miles an hour.

And if you want to soup up your ride, no problem, says Yehuda. Customers can order parts to make their Trekker a speed demon. “I produce the components and have the fastest scooters in the world,” says Yehuda. “And all you need to ride one is a smile in the morning.”

Yehuda, a graduate of industrial engineering at Connecticut University in the United States, has a model that can reach about 75 miles an hour within 15 seconds. “But that one’s not for sale,” he warns.

Buying a Trekker is good for the pocket book too, Yehuda points out. It costs about one seventh of a cent to drive it a mile. “We are selling a recession machine,” he says.

Born with a set of wheels

You can already find his colourful electric scooters on the streets of New York, says Yehuda, because people come to Israel, fall in love with them, pack them in a box and take them back home.

You don’t need a license to drive one, which makes it the best way to get to work if it’s close by, says Yehuda, and perfect for getting to the point of commute at a bus stop or train station.

Yehuda first got the idea for an electric scooter after seeing the Go-Ped, developed by American evangelical Christian Steve Patmont who visits Israel often. After leaving university he began tinkering with the idea, trying to come up with his own version.

At Connecticut Yehuda learned how to mass produce, not how to create “wheels” he says. “I was born with wheels. I know about wheels. And don’t think what I created is connected to my studies. There are things I knew before school. I went there because I wanted to learn how to [mass] produce, not do things one by one.”

There is a philosophy behind the Trekker brand. “What’s the reasoning of taking one and a half tons of metal to transport a 70 kilogram person?” asks Yehuda.

“Usually we’re driving with one person in a car. We need to use more mass transportation and we can get you to that mass transportation on a Trekker. You don’t need to know something to drive one. Just step on it. If you can level yourselves you can ride one.”

So simple you can fix it at home

Each machine is built by one person from start to finish. Yehuda believes it is the simplest and most reliable piece of transportation out there. It’s so simple people can even fix it at home, if parts break down.

Trekker now has a staff of 18 in Tel Aviv, and is speaking with possible partners in Switzerland, Holland, South Africa and Greece for developing the Trekker line in these countries. Yehuda isn’t ready to mass-produce without planning ahead. Customer service, he asserts, has to come first.

“I have a lot of people that are interested. But we aren’t expanding into America just yet. On the first day of opening there, we’d need to be able to merchandise for 350 million people. Since all these machines are based on service, we’d need to have the factories and service centers in America so people can get spare parts and service close to home,” he explains.

While you might have to wait a little while to buy a Trekker if you live in the US, the other solution is a trip to Europe or Israel, to pack one for the flight home.

h1

Oral drugs that can pack more of a punch

July 30, 2009

Professor Simon Benita

It may be the latest scientific trend, but Professor Simon Benita of the Hebrew University’s School of Pharmacy has been working with nanotechnology since long before it had a name.

His 25 years of research in nanotech has culminated in a new vehicle for oral drug delivery based on the microencapsulated double-coated nanocapsules that he developed.

Normally, our bodies’ defenses would stop and break down orally administered drugs, so that we only benefit from about three-quarters of their potential effectiveness. Now, thanks to P-gpBypass, Benita’s invention, important cancer and HIV drugs as well as a range of immunosupressants should be able to slip through those defenses to treat disease more effectively.

The oral route is preferred, but only 40 percent of all drugs are water-soluble. This means that many drugs are administered intravenously, which is less effective and may lead to unpleasant side effects, or, they are delivered orally, in which case they have limited bioavailability.

Slipping through our defenses

When delivered orally, Benita explains to ISRAEL21c, drugs activate an intestinal pump barrier, the P-gp efflux pump, and are broken down in the intestine and the liver, losing about a quarter of their potency in the process.

“We took advantage of nanotechnology to design a Trojan horse similar to Taxol [a cancer drug],” says Benita. “It’s in a nanocapsule embedded in a micro-sphere, and not releasing into the intestine. . . it’s not activating the P-gp efflux pump. . . it is so small, it slips through.”

At 100 nm, Benita’s drug-laden nanocapsules are a new drug delivery system that could make painful injections and intravenous lipophilic drugs a thing of the past.

Creating a new drug delivery mechanism, “is not as simple as it looks,” says Benita stressing that there are “many, many companies” in the industry. “We are targeting one of the most challenging pharmaceutical issues with regard to formulation. More than 50 percent of drugs existing, or as new chemical entities . . . are not water soluble,” he tells ISRAEL21c.

Encouraging results from animal testing

Benita’s solution means that pharmaceutical developers can work around the intestinal pump, bypassing the gut enzyme metabolism, delivering maximum drug power without the side effects.

Benita and his team of four at the School of Pharmacy tested his platform recently on the immunosuppressant tacrolimus which is given to transplant patients to help prevent rejection of their new organs. Their tests showed that they could deliver the drug and unlock 2.4 times its bioavailability, or active ingredients, since their size provides protection from the GI enzymes in the intestines.

These encouraging results in animal studies led the Hebrew University’s tech transfer arm, the Yissum Research Development Company, to enter into a deal with Israel-based Aurum Ventures MKI, which will test the platform with the aim of refining it for commercial success.

Aurum Ventures MKI is the technology investment arm of Morris Kahn, a prominent Israeli businessman, philanthropist and entrepreneur.

Israel excels in drug delivery

“The ability to deliver lipophilic drugs orally while bypassing specific potent barriers in the intestine and the liver carries tremendous potential,” says Yehuda Yarmut, the deputy CEO of Yissum. “Benita, a seasoned inventor and entrepreneur and co-founder of Novagali SA, one of Yissum’s most promising spin-offs, has once again demonstrated his ingenuity in developing a novel mechanism addressing many unmet medical needs.”

In Israel, a relatively small country, there appears to be a disproportionately large number of drug delivery companies. Much of this has to do with the fact that Israelis like to be entrepreneurs, but also, says Benita, because at the Hebrew University’s School of Pharmacy there is a large number of researchers who are very skilled in drug delivery technologies. “We are considered worldwide very strong in drug delivery,” he says.

The researchers both influence their students, and work themselves to create drug delivery companies and spin-offs. Some 25% of the patents at Yissum are in drug delivery, “because of the strong expertise in our department,” says Benita.

Benita founded the nanotech company Novagali in France 10 years ago for ocular delivery of drugs using nanoemulsions. The company currently has major products at various stages of development to tackle dry eye, allergy, glaucoma, retinopathies and more. Its formulations are based on the technology platforms of Novasorb and Eyeject, which optimize bioavailability of drugs as well as safety and comfort for the patient.

h1

Celebrating 25 years of civil liberties in Israel

July 30, 2009

Prof. Herman Schwartz creates civic-minded legal eagles in Israel.

Martin Luther King’s dream was that blacks and other minorities in America would enjoy the same civil rights as every other citizen of the United States. He paid for his dream with his life, but it eventually came true.

When Prof. Herman Schwartz, an American civil rights lawyer, first came to Israel 26 years ago, he saw a profound difference between the post Martin Luther King era in the US and the civil rights movement in Israel, with the movement in Israel lagging far behind.

To change that, in 1983 he founded the US/Israel Civil Liberties Law program to develop a human rights bar in Israel.

With two handpicked Israeli law fellows supported by the program every year, over the last two and a half decades the program has profoundly affected Israel’s civil rights movement, both in the legal sphere and in communities across the country, where the program has had a positive impact on the rights of Arabs and new immigrants from Ethiopia, as well as on laws that help to protect the environment and the elderly.

This year, prestigious guests from Israel and the US gathered in Tel Aviv to celebrate 25 years since Schwartz, who currently administers the program, started following his dream, with the help of the New Israel Fund and the American University Washington College of Law.

The anniversary celebrations included seminars with Prof. Aharon Barak the former Chief Justice of the Supreme Court of Israel, Prof. Claudio Grossman, the dean of the American University Washington College of Law, and Prof. Naomi Chazan, the president of the New Israel Fund. US Ambassador James B. Cunningham was also among those in attendance.

Fighting for justice and mercy

Schwartz, a director at the Washington College of Law Center for Human Rights and Humanitarian Law, as well as a member of the boards of the Foundation for a Civil Society, Helsinki Watch and other domestic and foreign public interest organizations, says that he came of age in the US civil liberties movement.

“I didn’t see that here in Israel and it seemed to me that both our precedence and practices in American law would be very helpful here,” he tells ISRAEL21c in Tel Aviv.

“I’ve always been strongly Zionist in believing in Israel as a proper place for the Jewish people; and it should be a place informed by what I consider to be main trends in the Jewish culture – justice and mercy and those things.”

As part of their fellowship, the chosen fellows spend one year in the US. While obtaining a Master’s degree in Civil Rights Law, they also intern with American groups such as the American Civil Liberties Union, Human Rights’ Watch and the Council on American Islamic Relations.

According to the New Israel Fund, co-sponsor of the US/Israel Civil Liberties Law program, its fellowship alumni have argued dozens of landmark cases, which have affected legislation and shaped public policies in Israel. Lasting effects can be felt in environmental and disabilities law, as well as in religious freedom and pluralism in Israel.

Helping Arab Israelis to help themselves

With Israel being the only true democracy in the Middle East, there is no doubt that the effects of this program have resonated throughout the region.

“People in my school and students from other countries have interacted with the fellows over the years,” says Schwartz, noting that the fellows have been an integral part of the large international civil liberties community.

“One of the major purposes of the program was for Arab lawyers in the Arab community to develop their own competent effort and not be dependent on the Jewish community,” says Schwartz. The Israeli Arab rights group Adalah has “been one of the shining examples of success in our project, with worldwide reputation and support,” he adds proudly.

A past fellow from the program is Bana Shoughry-Badarne, a Palestinian Israeli human rights attorney who now sits on the steering committee that helps to choose future fellows. She has worked on behalf of the Israeli Bedouin community and other vulnerable groups in Israel and inside the Palestinian community.

As part of a marginal community in Israel, the Bedouin “lost their land and their communities and had to build everything again and without basic rights like health clinics and schools,” says Shoughry-Badarne.

Copied in other countries

Today Shoughry-Badarne works in the sphere of prisoners’ rights to ensure that they aren’t mistreated.

The fellowship allowed her to obtain an advanced degree in the US and to help the communities she cares about.

Ensuring equal rights for Palestinian women living in Israel is also one of her priorities. Not only do these women have to fight the unfair norms in their own society, they also have to fight the Jewish establishment which may discriminate against them according to the nation’s religious law, she tells ISRAEL21c.

Based on its success in Israel, the program has expanded and now accepts applications from Central and East Europe. It has also been replicated at Columbia University Law School with the help of Schwartz, who has worked for human rights both in the US and abroad for over four decades.

He currently advises a number of former Soviet bloc countries on constitutional and human rights reform, and has represented the US a number of times at United Nations conventions.

h1

Israel to head the world’s largest R&D initiative

July 29, 2009

Israel belongs to the Asian continent, but when it comes to research and development the US and Europe seem closer to home. And like most countries operating in today’s global village, Israel relies on cooperation with industrial partners from the European Union and the US to propel its high-tech and biotech products into the world market.

As evidence of its leading role in research and development, Israel has been chosen to head the largest R&D network in the world, the “Eureka initiative”, a pan-European, inter-governmental initiative that supports European innovation and sees investments of 1.5 billion euro every year.

Since joining the program in 2000, Israel, the only non-European member country, has been among the most active of the 40 members.

In 1985, Eureka was set up as a legal framework within which European companies could collaborate and receive government funding. Thanks to a political push from France and Germany, Israel was granted permission to join Eureka as a full member.

“It’s a very unique occasion,” Israel Shamay, Israel’s national project coordinator for Eureka, from ” the Israeli Industry Center for R&D (MATIMOP) “, tells ISRAEL21c. However, Shamay believes that the vote that led to an Israeli representative being chosen to chair the network was an obvious choice, after Israel proved itself among the member countries.

“In the last three years, Israel became one of the five most active members in Eureka and had the same number of projects compared to [EU] countries, which are much bigger. Out of nearly 300 new projects initiated by Eureka, in 2008, we had 40 with Israeli companies participating in them.”

Successful Israel-EU partnerships

Some of the more successful pairings since Israel joined Eureka are between the Israeli agricultural company Veterix, and DeLaval, a Swedish milk industry giant. Veterix developed a capsule that sits in the stomach of a cow to monitor the health of the animal from within, and worked with the Swedish firm to co-develop the idea.

“This is an example that reflects the merits of Eureka,” says Shamay. “The partner is a prospective business partner. In this case the Swedish government shared the risk.”

Elbit Systems, the Israeli defense industries high tech firm, had several projects in Eureka. One was to take cameras intended for military purposes and develop them for the auto industry. If the windshield fogs up or if there is poor visibility, the camera can still see the road. It’s good for truckers, says Shamay.

A third success story is the partnership between Starhome, a Comverse subsidiary in Israel, and Nokia and Alcatel-Lucent to develop a smart home system.

Eureka is the largest joint project R&D initiative in the world. Main objectives are to foster R&D joint ventures between corporations, with financial support matched by representative countries.

Germany is now entering the chair position, with Israel to follow. The project maintains a troika system, with three representatives holding chair positions simultaneously – the past, present and future chairs. The name of the Israeli chairperson has not yet been announced.

Determining Eureka’s agenda

Shamay is hoping that Israel’s upcoming leading role in Eureka will impact positively on the country’s industrial development. “Over this period of one year, Israel will determine the agenda of Eureka and can prioritize along with our national interests,” he says, pointing out that Israel could initiate new funding schemes for startups and companies, bring more EU investment banks and investors to Israel and expose EU countries to Israel’s binational projects like the Red-Dead canal, proposed between Israel and Jordan.

Chief Scientist Dr. Eli Opper said in an interview with Israel’s financial newspaper, Globes: “During its year as president of Eureka, Israel will be able to set its agenda, which will enable us to promote important initiatives with European support, such as strengthening R&D in low technology industries or in other priority fields, such as the life sciences, water technologies and the environment.”

Operating like the Israel-US Binational Industrial Research and Development Foundation (the BIRD Foundation), Eureka has a legal entity – the foundation. The task of the foundation is to select projects that will be eligible for a virtual fund.

“It’s not like a common pot of money and then the commission selects projects for funding,” says Shamay. This is how Eureka is different from BIRD and other joint R&D funds: “Eureka funding comes from different national programs.

“In our case [funding comes from] the Chief Scientist’s Office. Eureka provides a platform to initiate this cooperation and provides a legal framework,” explains Shamay. “It’s important to note it’s a national task so we are involving the President of Israel, Israel’s Ministry of Foreign Affairs, the Ministry of Science and the Israel Venture Association. We invite all of them to take part in this opportunity,” he adds.

Israel has other successful partnerships underway in EU R&D programs, in the EU Seventh Framework Programme for R&D, and in Galileo, a global satellite navigation program.

© 2001-2008 ISRAEL21c.org. All rights reserved.

h1

Israeli High-tech exports jump

July 16, 2009

Sources inform ”Globes” that a sharp rise in Intel Israel’s operations led the jump.

Adrian Filut13 Jul 09

The Central Bureau of Statistics reports an unexpectedly favorable turnaround in Israel’s foreign trade in June 2009: high-tech exports rose, while the drop in other exports and in imports slowed. Israel’s trade deficit plummeted to a monthly average of $300 million in the first half of 2009 from $1.1 billion in 2008.

Export of goods rose by an annualized 1.2% in April-June in trend, after falling by an annualized 23.9% in January-March. Exports have been falling for nearly a year. Exports account for 45% of Israel’s GDP, and are a critical growth engine.

The financial crisis that erupted in September 2008 quickly spread to the real economy, and resulted in a slump in foreign trade. Economists attributed Israel’s recession to the plunge in global trade.

The Central Bureau of Statistics’ most encouraging figure is the annualized 20.5% jump in high-tech exports in April-June, after rising by an annualized 14.5% in January-March. High-tech exports account for about half of Israel’s total industrial exports, excluding diamonds. Exports of electronic components rose by 129.3% in April-June. Sources inform ”Globes” that the source of the increase was the new production line at the Intel Corporation (Nasdaq: INTC) fab in Kiryat Gat.

Israel’s trade deficit fell to $200 million in June, and to an annualized $4 billion in the first half of the year. The trade deficit was $13.2 billion in 2008.

Published by Globes [online], Israel business news – www.globes-online.com – on July 13, 2009

© Copyright of Globes Publisher Itonut (1983) Ltd. 2009